We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$47.1B
AUM Growth
-$899M
(-1.9%)
Cap. Flow
-$982M
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
967
New
122
Increased
219
Reduced
464
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$250M |
| 2 |
Starbucks
SBUX
|
+$152M |
| 3 |
CERN
Cerner Corp
CERN
|
+$122M |
| 4 |
Colgate-Palmolive
CL
|
+$87.1M |
| 5 |
Procter & Gamble
PG
|
+$77.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$456M |
| 2 |
Cisco
CSCO
|
+$392M |
| 3 |
Analog Devices
ADI
|
+$151M |
| 4 |
United Parcel Service
UPS
|
+$148M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$89.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.05% |
| 2 | Consumer Discretionary | 15.92% |
| 3 | Financials | 12.69% |
| 4 | Healthcare | 12.47% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Apple
AAPL
$4.57T
| $48.5M | 0.1% |
1,156,136
-1,081,436
| -48% | -$46.6M |
|
77
HealthEquity
HQY
$8.75B
| $48.1M | 0.1% |
794,933
-24,660
| -3% | -$1.34M |
|
78
Planet Fitness
PLNT
$3.78B
| $47.8M | 0.1% |
1,265,171
-103,996
| -8% | -$3.64M |
|
|
JBTM
79
JBT Marel
JBTM
$6.39B
| $46.8M | 0.1% |
412,800
-20,806
| -5% | -$2.38M |
|
|
PPLI
80
People Inc
PPLI
$3.1B
| $45.8M | 0.1% |
1,638,363
-400,251
| -20% | -$10.5M |
|
81
Guidewire Software
GWRE
$14.2B
| $45.4M | 0.1% |
562,141
+33,902
| +6% | +$2.73M |
|
82
Bright Horizons
BFAM
$3.86B
| $45.4M | 0.1% |
454,986
-62,916
| -12% | -$6.11M |
|
83
Exelon
EXC
$47B
| $44.7M | 0.09% |
1,605,244
-76,968
| -5% | -$2.08M |
|
84
PNC Financial Services
PNC
$101B
| $44.4M | 0.09% |
293,675
-51,894
| -15% | -$8.06M |
|
85
AMN Healthcare
AMN
$1.4B
| $43.9M | 0.09% |
773,834
-16,729
| -2% | -$909K |
|
86
Mondelez International
MDLZ
$79.9B
| $43.7M | 0.09% |
1,046,720
-92,602
| -8% | -$4.02M |
|
87
Littelfuse
LFUS
$11.6B
| $42.8M | 0.09% |
205,354
-32,110
| -14% | -$6.74M |
|
88
EOG Resources
EOG
$70.7B
| $42.5M | 0.09% |
404,149
+86,655
| +27% | +$9.34M |
|
89
HubSpot
HUBS
$10.5B
| $41.6M | 0.09% |
383,792
-68,799
| -15% | -$7.17M |
|
90
Chevron
CVX
$366B
| $40.5M | 0.09% |
354,777
-48,248
| -12% | -$5.77M |
|
91
Berkshire Hathaway Class B
BRK.B
$1.13T
| $39.9M | 0.08% |
200,251
+12,769
| +7% | +$2.62M |
|
|
TCF
92
DELISTED
TCF Financial Corporation Common Stock
TCF
| $39.9M | 0.08% |
729,959
-23,856
| -3% | -$1.34M |
|
93
MarketAxess Holdings
MKTX
$5.72B
| $39.2M | 0.08% |
180,475
-5,537
| -3% | -$1.14M |
|
|
TWOU
94
DELISTED
2U Inc
TWOU
| $39.2M | 0.08% |
15,548
-2,953
| -16% | -$6.83M |
|
95
BWX Technologies
BWXT
$15.6B
| $38.2M | 0.08% |
601,201
-82,389
| -12% | -$5.22M |
|
96
Honeywell
HON
$78B
| $38.2M | 0.08% |
292,459
-59,532
| -17% | -$8.24M |
|
|
ULTI
97
DELISTED
Ultimate Software Group Inc
ULTI
| $38.1M | 0.08% |
156,163
-4,808
| -3% | -$1.14M |
|
98
Tyler Technologies
TYL
$12.8B
| $37.8M | 0.08% |
+179,161
| New | +$35.8M |
|
99
Booking.com
BKNG
$161B
| $37.3M | 0.08% |
448,000
-342,525
| -43% | -$26.9M |
|
100
WEX
WEX
$6.31B
| $36.7M | 0.08% |
234,410
-23,587
| -9% | -$3.55M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2018 Portfolio in Review
As of Q1 2018, Loomis, Sayles & Company held 967 positions worth $47.1B, down 1.9% from $48B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Loomis, Sayles & Company's Q1 2018 filing shows 122 new, 219 increased, 464 reduced and 97 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M. The largest sale was Amazon, an estimated $456M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q1 2018 buy was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q1 2018, an estimated $250M increase.
- Loomis, Sayles & Company's biggest Q1 2018 reduction was Amazon, cutting an estimated $456M.
- Loomis, Sayles & Company fully exited Analog Devices in Q1 2018, selling an estimated $151M.
- Loomis, Sayles & Company's ten largest holdings make up 35% of its $47.1B portfolio in Q1 2018.
- Loomis, Sayles & Company opened 122 new positions and closed 97 in Q1 2018.
- Loomis, Sayles & Company's portfolio value fell 1.9% quarter-over-quarter to $47.1B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.